BRIEF-Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase 2 cGMP material
* Bird Rock Bio receives approval to start first in human
clinical trial for Namacizumab, enters into agreement with GE
Healthcare for process development and scale-up to provide
No comments:
Post a Comment